Evidence map›Paper›PMID 19898456›Full record

ReviewNature biotechnology2009

The challenges of sequencing by synthesis.

Carl W Fuller, Lyle R Middendorf, Steven A Benner, George M Church, Timothy Harris, Xiaohua Huang, Stevan B Jovanovich, John R Nelson, Jeffery A Schloss, David C Schwartz and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature biotechnology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed.

  1. Article
  2. The Fantastic Single-Molecule Techniques.Chemical & biomedical imaging · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Linezolid in the Focus of Antimicrobial Resistance ofInternational journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Recycling of Polymerase Chain Reaction (PCR) Kits.ACS sustainable chemistry & engineering · 2023
    Article
  18. Review
  19. Methods to improve the accuracy of next-generation sequencing.Frontiers in bioengineering and biotechnology · 2023
    Review
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carl W FullerGE Healthcare Life Sciences, Piscataway, New Jersey, USA. carl.fuller@alumni.upenn.edu
Lyle R Middendorf
Steven A Benner
George M Church
Timothy Harris
Xiaohua Huang
Stevan B Jovanovich
John R Nelson
Jeffery A Schloss
David C Schwartz
Dmitri V Vezenov

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA sequencing-by-synthesis (SBS) technology, using a polymerase or ligase enzyme as its core biochemistry, has already been incorporated in several second-generation DNA sequencing systems with significant performance. Notwithstanding the substantial success of these SBS platforms, challenges continue to limit the ability to reduce the cost of sequencing a human genome to $100,000 or less. Achieving dramatically reduced cost with enhanced throughput and quality will require the seamless integration of scientific and technological effort across disciplines within biochemistry, chemistry, physics and engineering. The challenges include sample preparation, surface chemistry, fluorescent labels, optimizing the enzyme-substrate system, optics, instrumentation, understanding tradeoffs of throughput versus accuracy, and read-length/phasing limitations. By framing these challenges in a manner accessible to a broad community of scientists and engineers, we hope to solicit input from the broader research community on means of accelerating the advancement of genome sequencing technology.

Indexed as

AnimalsDNAFluorescent DyesHumansOptical PhenomenaSequence Analysis, DNASubstrate SpecificitySurface PropertiesDNAFluorescent Dyes

Identifiers

PMID19898456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.